Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Mar 23
 -6.40 / -1.95%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 440.00, with a high estimate of 568.00 and a low estimate of 387.00. The median estimate represents a +36.95% increase from the last price of 321.29.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -26.33%
Growthannually 12.53%


Growthquarterly -6.58%
Growthannually 9.00%
Key to the earnings and sales forecast charts.